Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study group
Authors:
- Partha BasuPartha Basu
- for the IARC COVID‐19 Impact Study GroupFGfor the IARC COVID‐19 Impact Study Group
Open Access
- 3 February 2021
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 149 (1) , 97-107
Abstract
We conducted a study to document the impact of COVID‐19 pandemic on cancer screening continuum in selected low‐ and middle‐income countries (LMICs). LMICs having an operational cancer control plan committed to screen eligible individuals were selected. Managers/supervisors of cancer screening programs were invited to participate in an online survey and subsequent in‐depth interview. Managers/supervisors from 18 programs in 17 countries participated. Lockdown was imposed in all countries except Brazil. Screening was suspended for at least 30 days in 13 countries, while diagnostic‐services for screen‐positives were suspended in 9 countries. All countries except Cameroon, Bangladesh, India, Honduras and China managed to continue with cancer treatment throughout the outbreak. The participants rated service availability compared to pre‐COVID days on a scale of 0 (no activities) to 100 (same as before). A rating of ≤50 was given for screening services by 61.1%, diagnostic services by 44.4% and treatment services by 22.2% participants. At least 70% participants strongly agreed that increased noncompliance of screen‐positive individuals and staff being overloaded or overwhelmed with backlogs would deeply impact screening programs in the next 6 months at least. Although many of the LMICs were deficient in following the “best practices” to minimize service disruptions, at least some of them made significant efforts to improve screening participation, treatment compliance and program organization. A well‐coordinated effort is needed to reinitiate screening services in the LMICs, starting with a situational analysis. Innovative strategies adopted by the programs to keep services on‐track should be mutually shared.Keywords
This publication has 20 references indexed in Scilit:
- Healthy China 2030: moving from blueprint to action with a new focus on public healthThe Lancet Public Health, 2019
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytologyJournal of Gynecologic Oncology, 2019
- Breast Cancer Screening Program in Morocco: Status of implementation, organization and performanceInternational Journal of Cancer, 2018
- Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013BMC Cancer, 2018
- Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplarThe Lancet Oncology, 2018
- Cervical cancer screening in rural Bhutan with the care HPV test on self-collected samples: an ongoing cross-sectional, population-based study (REACH-Bhutan)BMJ Open, 2017
- Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low‐ and lower‐middle‐income countriesInternational Journal of Gynecology & Obstetrics, 2017
- Influence of delay on survival in patients with breast cancer: a systematic reviewThe Lancet, 1999
- Factors predicting delayed presentation of symptomatic breast cancer: a systematic reviewThe Lancet, 1999